Cancer prevalence in the United Kingdom: estimates for 2008

BACKGROUND: Identifying and addressing the requirements of cancer survivors is currently a high priority for the NHS, yet little is known about the population of cancer survivors in the United Kingdom. METHODS: Data from cancer registries in England, Northern Ireland, Scotland and Wales were analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddams, J, Brewster, D, Gavin, A, Steward, J, Elliott, J, Utley, M, Møller, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720244/
https://www.ncbi.nlm.nih.gov/pubmed/19568236
http://dx.doi.org/10.1038/sj.bjc.6605148
_version_ 1782170125277855744
author Maddams, J
Brewster, D
Gavin, A
Steward, J
Elliott, J
Utley, M
Møller, H
author_facet Maddams, J
Brewster, D
Gavin, A
Steward, J
Elliott, J
Utley, M
Møller, H
author_sort Maddams, J
collection PubMed
description BACKGROUND: Identifying and addressing the requirements of cancer survivors is currently a high priority for the NHS, yet little is known about the population of cancer survivors in the United Kingdom. METHODS: Data from cancer registries in England, Northern Ireland, Scotland and Wales were analysed to provide limited-duration prevalence estimates for 2004. Log-linear regression models were used to extend these to complete prevalence estimates. Trends in prevalence from 2000 to 2004 were used to project complete prevalence estimates forward from 2004 to 2008. RESULTS: We estimated that in total, there were 2 million cancer survivors in the United Kingdom at the end of 2008, ∼3% of the population overall and 1 in 8 of those aged 65 years and more. Prostate and female breast cancers were the most prevalent. The number of cancer survivors is increasing by ∼3% each year. Estimates are also provided by time since diagnosis. CONCLUSION: These estimates are the most up-to-date available, and as such will be useful for statutory and voluntary sector organisations that are responsible for planning and providing treatment and support to cancer survivors in the United Kingdom.
format Text
id pubmed-2720244
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27202442010-08-04 Cancer prevalence in the United Kingdom: estimates for 2008 Maddams, J Brewster, D Gavin, A Steward, J Elliott, J Utley, M Møller, H Br J Cancer Epidemiology BACKGROUND: Identifying and addressing the requirements of cancer survivors is currently a high priority for the NHS, yet little is known about the population of cancer survivors in the United Kingdom. METHODS: Data from cancer registries in England, Northern Ireland, Scotland and Wales were analysed to provide limited-duration prevalence estimates for 2004. Log-linear regression models were used to extend these to complete prevalence estimates. Trends in prevalence from 2000 to 2004 were used to project complete prevalence estimates forward from 2004 to 2008. RESULTS: We estimated that in total, there were 2 million cancer survivors in the United Kingdom at the end of 2008, ∼3% of the population overall and 1 in 8 of those aged 65 years and more. Prostate and female breast cancers were the most prevalent. The number of cancer survivors is increasing by ∼3% each year. Estimates are also provided by time since diagnosis. CONCLUSION: These estimates are the most up-to-date available, and as such will be useful for statutory and voluntary sector organisations that are responsible for planning and providing treatment and support to cancer survivors in the United Kingdom. Nature Publishing Group 2009-08-04 2009-06-30 /pmc/articles/PMC2720244/ /pubmed/19568236 http://dx.doi.org/10.1038/sj.bjc.6605148 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Maddams, J
Brewster, D
Gavin, A
Steward, J
Elliott, J
Utley, M
Møller, H
Cancer prevalence in the United Kingdom: estimates for 2008
title Cancer prevalence in the United Kingdom: estimates for 2008
title_full Cancer prevalence in the United Kingdom: estimates for 2008
title_fullStr Cancer prevalence in the United Kingdom: estimates for 2008
title_full_unstemmed Cancer prevalence in the United Kingdom: estimates for 2008
title_short Cancer prevalence in the United Kingdom: estimates for 2008
title_sort cancer prevalence in the united kingdom: estimates for 2008
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720244/
https://www.ncbi.nlm.nih.gov/pubmed/19568236
http://dx.doi.org/10.1038/sj.bjc.6605148
work_keys_str_mv AT maddamsj cancerprevalenceintheunitedkingdomestimatesfor2008
AT brewsterd cancerprevalenceintheunitedkingdomestimatesfor2008
AT gavina cancerprevalenceintheunitedkingdomestimatesfor2008
AT stewardj cancerprevalenceintheunitedkingdomestimatesfor2008
AT elliottj cancerprevalenceintheunitedkingdomestimatesfor2008
AT utleym cancerprevalenceintheunitedkingdomestimatesfor2008
AT møllerh cancerprevalenceintheunitedkingdomestimatesfor2008

Ejemplares similares